Qin Wen
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma with esophagogastric varices after progression on first-line lenvatinib combined with PD-1 inhibitor.
Journal: World journal of surgical oncology
Published: November 07, 2024
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer.
Journal: Cell death & disease
Published: October 10, 2024
YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression.
Journal: Cellular and molecular life sciences : CMLS
Published: October 24, 2023
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.
Journal: Molecular cancer
Published: December 09, 2022
Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
Journal: Frontiers in immunology
Published: September 30, 2022
FDFT1/FGFR2 rearrangement: A newly identified anlotinib-sensitive FGFR2 variant in cholangiocarcinoma.
Journal: Cancer treatment and research communications
Published: March 09, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026